F
Francesco Rubino
Researcher at King's College London
Publications - 133
Citations - 12607
Francesco Rubino is an academic researcher from King's College London. The author has contributed to research in topics: Type 2 diabetes & Diabetes mellitus. The author has an hindex of 41, co-authored 131 publications receiving 10277 citations. Previous affiliations of Francesco Rubino include Sapienza University of Rome & HealthPartners.
Papers
More filters
Journal ArticleDOI
Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
Geltrude Mingrone,Simona Panunzi,Andrea De Gaetano,Caterina Guidone,Amerigo Iaconelli,Laura Leccesi,Giuseppe Nanni,Alfons Pomp,Marco Castagneto,Giovanni Ghirlanda,Francesco Rubino +10 more
TL;DR: In severely obese patients with type 2 diabetes, bariatric surgery resulted in better glucose control than did medical therapy and preoperative BMI and weight loss did not predict the improvement in hyperglycemia after these procedures.
Journal ArticleDOI
Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial
Geltrude Mingrone,Geltrude Mingrone,Simona Panunzi,Andrea De Gaetano,Caterina Guidone,Amerigo Iaconelli,Giuseppe Nanni,Marco Castagneto,Stefan R. Bornstein,Francesco Rubino +9 more
TL;DR: Surgery is more effective than medical treatment for the long-term control of obese patients with type 2 diabetes and should be considered in the treatment algorithm of this disease, however, continued monitoring of glycaemic control is warranted because of potential relapse of hyperglycaemia.
Journal ArticleDOI
How Do We Define Cure of Diabetes
John B. Buse,Sonia Caprio,William T. Cefalu,Antonio Ceriello,Stefano Del Prato,Silvio E. Inzucchi,Sue McLaughlin,Gordon L. Phillips,R. Paul Robertson,Francesco Rubino,Richard Kahn,M. Sue Kirkman +11 more
TL;DR: A consensus group of experts comprised of experts in pediatric and adult endocrinology, diabetes education, transplantation, metabolism, bariatric/metabolic surgery, and (for another perspective) hematology-oncology met in June 2009 to discuss issues.
Journal ArticleDOI
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations
Francesco Rubino,David M. Nathan,Robert H. Eckel,Philip R. Schauer,K. George M.M. Alberti,Paul Zimmet,Stefano Del Prato,Linong Ji,Shaukat Sadikot,William H. Herman,Stephanie A. Amiel,Lee M. Kaplan,Gaspar Taroncher-Oldenburg,David E. Cummings +13 more
TL;DR: Although additional studies are needed to further demonstrate long-term benefits, there is sufficient clinical and mechanistic evidence to support inclusion of metabolic surgery among antidiabetes interventions for people with T2D and obesity.
Journal ArticleDOI
Practical recommendations for the management of diabetes in patients with COVID-19.
Stefan R. Bornstein,Francesco Rubino,Francesco Rubino,Kamlesh Khunti,Geltrude Mingrone,Geltrude Mingrone,David Hopkins,David Hopkins,Andreas L. Birkenfeld,Bernhard O. Boehm,Bernhard O. Boehm,Stephanie A. Amiel,Richard I. G. Holt,Jay S. Skyler,J. Hans DeVries,Eric Renard,Robert H. Eckel,Paul Zimmet,Kurt George Alberti,Josep Vidal,Bruno Geloneze,Juliana C.N. Chan,Linong Ji,Barbara Ludwig +23 more
TL;DR: An international panel of experts in the field of diabetes and endocrinology is formed to provide some guidance and practical recommendations for the management of diabetes during the COVID-19 pandemic.